IOBENGUANE for Neuroblastoma recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where IOBENGUANE was used for Neuroblastoma recurrent.
Most Reported Side Effects for IOBENGUANE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Mucosal inflammation | 12 | 42.9% | 1 | 6 |
| Neutropenia | 12 | 42.9% | 0 | 12 |
| Febrile neutropenia | 9 | 32.1% | 5 | 3 |
| Haematotoxicity | 7 | 25.0% | 1 | 0 |
| Bk virus infection | 6 | 21.4% | 5 | 0 |
| Cytomegalovirus infection | 6 | 21.4% | 5 | 0 |
| Disease progression | 6 | 21.4% | 4 | 0 |
| Graft versus host disease | 6 | 21.4% | 5 | 0 |
Other Indications for IOBENGUANE
Other Drugs Used for Neuroblastoma recurrent
DINUTUXIMAB (102)
TEMOZOLOMIDE (84)
CYCLOPHOSPHAMIDE (77)
IRINOTECAN (74)
TOPOTECAN (56)
ETOPOSIDE (54)
CARBOPLATIN (39)
NAXITAMAB-GQGK (38)
IFOSFAMIDE (21)
LORLATINIB (21)